Litigation Details for AstraZeneca AB v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2019)
✉ Email this page to a colleague
AstraZeneca AB v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-11-03 |
Court | District Court, N.D. West Virginia | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Irene Patricia Murphy Keeley |
Jury Demand | Referred To | ||
Patents | 10,166,247; 7,759,328; 7,967,011; 8,143,239; 8,575,137 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AstraZeneca AB v. Mylan Pharmaceuticals Inc.
Details for AstraZeneca AB v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2021-03-01 | 181 | Memorandum & Opinion | add infringement claims for U.S. Patent No. 10,166,247 (the “’247 patent”) (Dkt. No. 89), and deleted its…States Patent No. 7,759,328 (“the ’328 Patent”); claims 12, 13, 18, and 19 of United States Patent No. …the ’239 Patent”); and claims 10 and 19 of United States Patent No. 8,575,137 (“the ’137 Patent”) (collectively…History of Patents-In-Suit The Patent and Trademark Office (“PTO”) issued the patents-in- suit… expiration of the patents-in-suit. The Drug Price Competition and Patent Term Restoration Act | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |